Prime Capital Investment Advisors, LLC
Position in EDIT — Editas Medicine, Inc.
CIK 1731446
OVERLAND PARK, KS
Position in EDIT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$66,964
+$8,455 QoQ
Shares Held
27,111
-5.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prime Capital Investment Advisors, LLC holds $14,447,509 across 15 Biotechnology names. EDIT ranks #10 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,916 | $10,752,058 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,334 | $1,042,224 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
15,826 | $992,290 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
11,343 | $369,101 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
3,971 | $298,182 | |
| 6 | IMTX |
Immatics N.V.
|
30,000 | $295,200 | |
| 7 | MRNA |
Moderna, Inc.
|
4,639 | $235,661 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
18,870 | $144,732 |
All Filings in EDIT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,964 | 27,111 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $58,509 | 28,541 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $101,389 | 29,219 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $70,967 | 32,258 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $55,501 | 47,846 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $62,896 | 49,525 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||